Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Saturday, January 19, 2019 · 474,116,104 Articles · 3+ Million Readers

Antidiabetic Drug Market Opportunities by Key Players, Regional Segmentation and Forecasts, 2018 – 2025

PUNE, INDIA, June 29, 2018 /EINPresswire.com/ -- Global Antidiabetic Drug Industry

New Study on “2018-2025 Antidiabetic Drug Market Global Key Player, Demand, Growth, Opportunities and Analysis Forecast” added to Wise Guy Reports Database

This report studies the global Antidiabetic Drug market status and forecast, categorizes the global Antidiabetic Drug market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

The global Antidiabetic Drug market is valued at 49600 million US$ in 2017 and will reach 96700 million US$ by the end of 2025, growing at a CAGR of 10.0% during 2018-2025.

The major manufacturers covered in this report
Sanofi-Aventis
Eli Lilly
Oramed
Takeda
Boehringer Ingelheim
Novo Nordisk
Halozyme Therapeutics
Bristol-Myers Squibb
Pfizer
Tonghua Dongbao
Biocon
Wockhardt

Try Sample Report @ https://www.wiseguyreports.com/sample-request/3219955-global-antidiabetic-drug-market-research-report-2018

Diabetes mellitus is a kind of chronic comprehensive disease mainly caused by glucose metabolism disorder due to absolute or relative deficiency of insulin or decreased insulin sensitivity of target cells. The occurrence of type 2 diabetes mellitus is a combination of peripheral insulin resistance and β cell dysfunction. the result of. When diabetes patients undergo diet and exercise therapy and diabetes care education, blood glucose control can still not reach the treatment goals, the need for drug treatment-Antidiabetic Drug
The global anti-diabetic drug market is expected to witness significant growth during the forecast period. This growth is attributed due to increasing prevalence of diabetes and rising demand for oral anti-diabetic drugs. In addition, sedentary lifestyle, increasing the percentage of obesity, high-stress levels are considered as a major driving factor for the growth of oral anti-diabetic drugs market. Furthermore, technological advancement and medical reimbursements can also help in fuelling the growth of oral antidiabetic drug market. However, the high cost of drugs is considered as a major restraint for the market. Nonetheless ongoing research and huge market potential can bring growth opportunities for anti-diabetic market within the forecast period.
Based on the class of drug, the global anti-diabetic drug market is segmented into five types: sulfonylureas, meglitinides, biguanides, alpha-glucosidase inhibitors and others. Sulphonylureas segment of oral anti-diabetic drugs market accounted for the largest market share in 2018followed by biguanides derivatives. Sulfonylureas were the largest segment and acquired around 37% of world market share followed by biguanide derivatives in 2018 Sulfonylureas are a class of organic compounds used in medicine and agriculture. They are antidiabetic drugs widely used in the management of type 2 diabetes mellitus. They act by increasing insulin release from the beta cells in the pancreas.
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
North America
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Alpha-Glucosidase Inhibitors
Biguanides, Sulphonylureas
Glp-1 Agonist
Meglitinides
Dpp-4 Inhibitors
Sglt–2
Thiazolodinediones
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Type I Diabetes
Type II Diabetes

The study objectives of this report are:
To analyze and study the global Antidiabetic Drug sales, value, status (2013-2017) and forecast (2018-2025).
Focuses on the key Antidiabetic Drug manufacturers, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Antidiabetic Drug are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Antidiabetic Drug Manufacturers
Antidiabetic Drug Distributors/Traders/Wholesalers
Antidiabetic Drug Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Antidiabetic Drug market, by end-use.
Detailed analysis and profiles of additional market players.

For Detailed Reading Please visit WiseGuy Reports @ https://www.wiseguyreports.com/reports/3219955-global-antidiabetic-drug-market-research-report-2018

Some points from table of content:

Global Antidiabetic Drug Market Research Report 2018
1 Antidiabetic Drug Market Overview
1.1 Product Overview and Scope of Antidiabetic Drug
1.2 Antidiabetic Drug Segment by Type (Product Category)
1.2.1 Global Antidiabetic Drug Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Antidiabetic Drug Production Market Share by Type (Product Category) in 2017
1.2.3 Alpha-Glucosidase Inhibitors
1.2.4 Biguanides, Sulphonylureas
1.2.5 Glp-1 Agonist
1.2.6 Meglitinides
1.2.7 Dpp-4 Inhibitors
1.2.8 Sglt–2
1.2.9 Thiazolodinediones
1.3 Global Antidiabetic Drug Segment by Application
1.3.1 Antidiabetic Drug Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Type I Diabetes
1.3.3 Type II Diabetes
1.4 Global Antidiabetic Drug Market by Region (2013-2025)

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here

Powered by EIN Presswire


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release